EID Parry acquires Bayer's Chilean unit Alimtec

As part of the growth strategy for the nutraceuticals business, EID Parry (India) Ltd, has acquired 100% stake in Alimtec S.A, Chile, a part of the Bayer Group. The acquisition is by way of purchase of the stake from Bayer Finance and Portfolio Management S.A., and Nunhems Chile S.A., subsidiaries of Bayer AG.
 
With this acquisition, EID Parry would ensure reliable sourcing of astaxanthin for its subsidiary, US Nutraceuticals LLC (Valensa). With Valensa’s strength in developing astaxanthin based formulations, this acquisition will culminate in value creation for the nutraceuticals business. The entire production of Alimtec will be used by Valensa for its astaxanthin products catering to USA and Europe markets.
 
EID Parry is a leading manufacturer and exporter of certified organic spirulina and carotenoids like natural beta carotene, astaxanthin and tomato lycopene. The company is a global leader in microalgal technology and has commercialised 3 major microalgae sources of nutraceuticals – spirulina, dunaliella salina (Source of natural beta carotene) and haematococcus pluvialis (source of astaxanthin).
 
Alimtec is active in the business of producing haematococcus pluvialis (H. pluvialis) biomass, a cultured micro-algae that is a rich natural source of astaxanthin for human use.